Basilea Pharmaceutica has selected Dotmatics' suite of solutions for pre-clinical research informatics, which allows analyzing, registering and managing scientific data.
The platform provides an electronic laboratory notebook for chemistry and biology experiments, the capacity to query and report research data, and to visualize with chemical intelligence.
Basilea CSO Laurenz Kellenberger said, "With the integrated Dotmatics platform tailored to Basilea's specific needs, we are further enhancing the way we globally consolidate and learn from biological and chemical research data."
Dotmatics CEO Stephen Gallagher said, "We are committed to delivering high quality solutions and services to ensure that the informatics requirements of Basilea's R & D are fulfilled."
The key features of the platform include Vortex, Bioregister, Pinpoint, Studies Notebook, Gateway, D40 and Nucleus.
